197 161

Cited 0 times in

Therapeutic effect of cell permeable peptide-conjugated methotrexate on mouse model of psoriasis induced by imiquimod

DC FieldValueLanguage
dc.contributor.author뱜바 다쉬룸베-
dc.date.accessioned2015-12-24T08:51:49Z-
dc.date.available2015-12-24T08:51:49Z-
dc.date.issued2012-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/134398-
dc.descriptionDept. of Medical Science/박사-
dc.description.abstractOral methotrexate (MTX) is an effective treatment for psoriasis being used over 50 years. However, common drug-related toxicities such as myelosuppresion, gastrointestinal irritation, nephrotoxicity, hepatotoxicity, and pulmonary fibrosis deter physicians from a prolonged prescription of MTX. These adverse effects may be minimized by administering MTX topically, using an effective drug delivery system. The aim of this work is to evaluate efficacy and safety of a cell permeable, protein transduction domain (PTD)-conjugated, MTX on imiquimod (IQM)-induced psoriasis-like skin inflammation in BALB/c mice. Topical application of cell permeable-MTX alleviated IQM-induced psoriasiform skin inflammation in mice. The cumulative PASI score of 1% PTD-MTX-applied mice was the lowest (5.350.29) followed by intraperitoneal (IP) MTX-injected (6.151.22), 0.1% PTD-MTX-applied (7.050.57), and IQM alone applied groups (8.150.58) in ascending order. Increased number of immune cells in the skin including epidermal MHC-II+ cells and dermal MHC-II+, CD11c+, CD4+ and IL-17A producing δ TCR+ cells in IQM-applied mice were normalized by both IP-MTX and cell permeable MTX. In addition, increased levels of IL-23, IL-17A and IL-22 in the skin were reduced by both IP-MTX and cell permeable MTX as well. However, altered composition of spleen cells induced by IQM was only affected by IP injection of MTX but not by cell permeable MTX. Besides, cell permeable MTX had no toxic effect on the liver, kidney and myeloid cells, unlike IP-MTX. In conclusion, topically applied, cell permeable MTX ameliorated IQM-induced psoriasiform skin inflammation without systemic immune suppressive nor toxic effects.-
dc.description.statementOfResponsibilityopen-
dc.publisherGraduate School, Yonsei University-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleTherapeutic effect of cell permeable peptide-conjugated methotrexate on mouse model of psoriasis induced by imiquimod-
dc.title.alternative이미퀴모드에 의해 유발된 건선양 피부염에서의 PTD-Methotrexate의 치료효과-
dc.typeThesis-
dc.contributor.alternativeNameByamba, Dashlkhumbe-
dc.type.localDissertation-
Appears in Collections:
1. College of Medicine (의과대학) > Others (기타) > 3. Dissertation

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.